comparemela.com

Latest Breaking News On - Amsterdam stock exchange pharm - Page 1 : comparemela.com

Pharming Group to report first quarter 2024 financial

Leiden, the Netherlands, April 24, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms it will report its preliminary.

Noord hollandUnited kingdomCity ofUnited statesMichael levitanPharming groupnv euronext amsterdamLifespring life sciences communicationVp investor relations corporate communicationsPharming groupEuronext amsterdamNorth americaMiddle eastSpring life sciences communicationAmsterdam stock exchange pharmPharming groupnv

Pharming announces completion of enrollment in pediatric

This multinational Phase III study is evaluating leniolisib tablets in children aged 4 to 11 years with APDS, a rare primary immunodeficiency .

United statesUnited kingdomCity ofNoord hollandMichael levitanChristina renfroeAnurag relanExchange commissionDrug administrationPharming groupnvVp investor relations corporate communicationsLifespring life sciences communicationPharming groupChief medical officerActivated phosphoinositideEuropean economic area

Pharming Group to report third quarter 2023 financial

Leiden, The Netherlands, October 12, 2023: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms it will report its.

Noord hollandUnited statesCity ofUnited kingdomHeather robertsonMichael levitanInvestor relations corporate communicationsPharming groupnv euronext amsterdamLifespring life sciences communicationPharming groupVp investor relations corporate communicationsEuronext amsterdamNorth americaMiddle eastInvestor relationsCorporate communications

Pharming Group reports on results of the 2023 Extraordinary

Leiden, The Netherlands, September 25, 2023: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext: PHARM/Nasdaq: PHAR) announces today that the.

City ofUnited kingdomNoord hollandUnited statesDeborah jornRichard petersHeather robertsonMichael levitanPaul sekhriPharming groupnvVp investor relations corporate communicationsCompany euronextPharming groupnv euronext amsterdamPharming groupLifespring life sciences communicationInvestor relations corporate communications

vimarsana © 2020. All Rights Reserved.